Allied Market Research

2025

Influenza Vaccination Market

Influenza Vaccination Market Size, Share, Competitive Landscape and Trend Analysis Report, by Product-based Segmentation, by Distribution Channel-based Segmentation, by End User-based Segmentation and, by Geographic-based Segmentation : Opportunity Analysis and Industry Forecast, 2023-2032

AT : Other

Select an option
Author's: | Lalit Janardhan Katare
Publish Date:

Get Sample to Email

The global Influenza vaccination market report covers market size, share, and growth rate (CAGR %) for various segments at regional and country levels. Along with various market dynamics such as drivers, restraints, market trends, and opportunities, the market overview section of the report highlights the qualitative aspect of the market. Furthermore, the section covers the market snapshot and key findings, in terms of investment opportunity and market overview. The report further includes a detailed competitive landscape comprising comprehensive profiles of leading players. The top players are assessed depending on their revenue size, market share, geographical presence, recent developments & strategic initiatives, and overall contribution to the market.

Key players identified in this report are Sanofi-Aventis, GlaxoSmithKline, Novo Nordisk, Novartis, EmergentBioSolutions, Pfizer, Merck, AstraZeneca, Baxter International, Abbott Laboratories

Market Snapshot

Report Metric

Details

Market size available for the years

2032

Base year considered

2023

Forecast period

2024

Forecast unit

Value (USD)

Segments covered

by product-based segmentation, by distribution channel-based segmentation, by end user-based segmentation, by geographic-based segmentation

Companies covered

Sanofi-Aventis, GlaxoSmithKline, Novo Nordisk, Novartis, EmergentBioSolutions, Pfizer, Merck, AstraZeneca, Baxter International, Abbott Laboratories

Key Inclusions

  • Qualitative as well as quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors

  • Analysis at regional and country level, which highlights the consumption of the product or service in the different geographies.

  • Extensive company profiles section, which includes different pointers such as company overview, key executive, company snapshot, business performance, product/service portfolio, R&D spending, and key strategies and developments of the major market players.

  • The current and estimated market outlook of the Influenza vaccination market with respect to recent developments which include analysis of drivers, market trends, and growth opportunities

  • Free 20% customization and post-sales support

Influenza Vaccination Market Report Highlights

Aspects Details
icon_5
By Product-based Segmentation
  • Influenza Vaccines
  • Pneumonia Vaccines
icon_6
By Distribution Channel-based Segmentation
  • Direct Marketing
  • Retailers
  • Clinicians
icon_7
By End User-based Segmentation
  • Pediatrics
  • Adults
  • Geriatric Population
icon_8
By Geographic-based Segmentation
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
icon_9
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Russia, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Thailand, Malaysia, Indonesia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, UAE, Argentina, Rest of LAMEA)
icon_10
Key Market Players

Abbott Laboratories, Sanofi-Aventis, EmergentBioSolutions, Novo Nordisk, Pfizer, Novartis, Merck, GlaxoSmithKline, Baxter International, AstraZeneca

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

Influenza Vaccination Market

Opportunity Analysis and Industry Forecast, 2023-2032